Skip to main content
  • Saved

A Meta-Analysis Assessing Additional LDL-C Reduction From Addition of a Bile Acid Sequestrant to Statin Therapy - PubMed

A Meta-Analysis Assessing Additional LDL-C Reduction From Addition of a Bile Acid Sequestrant to Statin Therapy - PubMed

Source : https://www.ncbi.nlm.nih.gov/pubmed/32416177

Background: Statins are the first line therapy for reducing low-density lipoprotein cholesterol (LDL-c). However, there are secondary prevention patients who are either intolerant to maximal statin therapy or do not get adequate effects from a high-intensity statin.